Copyright Reports & Markets. All rights reserved.

Global Bacille Calmette-Guerin Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bacille Calmette-Guerin Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Immune
    • 1.3.3 Therapy
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bacille Calmette-Guerin Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Private Distribution Channel
    • 1.4.3 Public Distribution Channel
  • 1.5 Global Bacille Calmette-Guerin Vaccine Market Size & Forecast
    • 1.5.1 Global Bacille Calmette-Guerin Vaccine Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Bacille Calmette-Guerin Vaccine Sales Quantity (2019-2030)
    • 1.5.3 Global Bacille Calmette-Guerin Vaccine Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Bacille Calmette-Guerin Vaccine Product and Services
    • 2.1.4 Merck Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Sanofi Pasteur
    • 2.2.1 Sanofi Pasteur Details
    • 2.2.2 Sanofi Pasteur Major Business
    • 2.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product and Services
    • 2.2.4 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sanofi Pasteur Recent Developments/Updates
  • 2.3 Japan BCG Lab
    • 2.3.1 Japan BCG Lab Details
    • 2.3.2 Japan BCG Lab Major Business
    • 2.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product and Services
    • 2.3.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Japan BCG Lab Recent Developments/Updates
  • 2.4 China National Biotec
    • 2.4.1 China National Biotec Details
    • 2.4.2 China National Biotec Major Business
    • 2.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Product and Services
    • 2.4.4 China National Biotec Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 China National Biotec Recent Developments/Updates
  • 2.5 Serum Institute of India
    • 2.5.1 Serum Institute of India Details
    • 2.5.2 Serum Institute of India Major Business
    • 2.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Product and Services
    • 2.5.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Serum Institute of India Recent Developments/Updates
  • 2.6 Intervax
    • 2.6.1 Intervax Details
    • 2.6.2 Intervax Major Business
    • 2.6.3 Intervax Bacille Calmette-Guerin Vaccine Product and Services
    • 2.6.4 Intervax Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Intervax Recent Developments/Updates
  • 2.7 GSBPL
    • 2.7.1 GSBPL Details
    • 2.7.2 GSBPL Major Business
    • 2.7.3 GSBPL Bacille Calmette-Guerin Vaccine Product and Services
    • 2.7.4 GSBPL Bacille Calmette-Guerin Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 GSBPL Recent Developments/Updates

3 Competitive Environment: Bacille Calmette-Guerin Vaccine by Manufacturer

  • 3.1 Global Bacille Calmette-Guerin Vaccine Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Manufacturer (2019-2024)
  • 3.3 Global Bacille Calmette-Guerin Vaccine Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Bacille Calmette-Guerin Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Bacille Calmette-Guerin Vaccine Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Bacille Calmette-Guerin Vaccine Manufacturer Market Share in 2023
  • 3.5 Bacille Calmette-Guerin Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Bacille Calmette-Guerin Vaccine Market: Region Footprint
    • 3.5.2 Bacille Calmette-Guerin Vaccine Market: Company Product Type Footprint
    • 3.5.3 Bacille Calmette-Guerin Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bacille Calmette-Guerin Vaccine Market Size by Region
    • 4.1.1 Global Bacille Calmette-Guerin Vaccine Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Bacille Calmette-Guerin Vaccine Consumption Value by Region (2019-2030)
    • 4.1.3 Global Bacille Calmette-Guerin Vaccine Average Price by Region (2019-2030)
  • 4.2 North America Bacille Calmette-Guerin Vaccine Consumption Value (2019-2030)
  • 4.3 Europe Bacille Calmette-Guerin Vaccine Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Bacille Calmette-Guerin Vaccine Consumption Value (2019-2030)
  • 4.5 South America Bacille Calmette-Guerin Vaccine Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Bacille Calmette-Guerin Vaccine Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 5.2 Global Bacille Calmette-Guerin Vaccine Consumption Value by Type (2019-2030)
  • 5.3 Global Bacille Calmette-Guerin Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 6.2 Global Bacille Calmette-Guerin Vaccine Consumption Value by Application (2019-2030)
  • 6.3 Global Bacille Calmette-Guerin Vaccine Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 7.2 North America Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 7.3 North America Bacille Calmette-Guerin Vaccine Market Size by Country
    • 7.3.1 North America Bacille Calmette-Guerin Vaccine Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Bacille Calmette-Guerin Vaccine Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 8.2 Europe Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 8.3 Europe Bacille Calmette-Guerin Vaccine Market Size by Country
    • 8.3.1 Europe Bacille Calmette-Guerin Vaccine Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Bacille Calmette-Guerin Vaccine Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Bacille Calmette-Guerin Vaccine Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 10.2 South America Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 10.3 South America Bacille Calmette-Guerin Vaccine Market Size by Country
    • 10.3.1 South America Bacille Calmette-Guerin Vaccine Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Bacille Calmette-Guerin Vaccine Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Bacille Calmette-Guerin Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Bacille Calmette-Guerin Vaccine Market Drivers
  • 12.2 Bacille Calmette-Guerin Vaccine Market Restraints
  • 12.3 Bacille Calmette-Guerin Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bacille Calmette-Guerin Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bacille Calmette-Guerin Vaccine
  • 13.3 Bacille Calmette-Guerin Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bacille Calmette-Guerin Vaccine Typical Distributors
  • 14.3 Bacille Calmette-Guerin Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Bacille Calmette-Guerin Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
    According to our (Global Info Research) latest study, the global Bacille Calmette-Guerin Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of during review period.
    This report is a detailed and comprehensive analysis for global Bacille Calmette-Guerin Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Bacille Calmette-Guerin Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Bacille Calmette-Guerin Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Bacille Calmette-Guerin Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Bacille Calmette-Guerin Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bacille Calmette-Guerin Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bacille Calmette-Guerin Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Bacille Calmette-Guerin Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Immune
    Therapy
    Market segment by Application
    Private Distribution Channel
    Public Distribution Channel
    Major players covered
    Merck
    Sanofi Pasteur
    Japan BCG Lab
    China National Biotec
    Serum Institute of India
    Intervax
    GSBPL
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Bacille Calmette-Guerin Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bacille Calmette-Guerin Vaccine, with price, sales quantity, revenue, and global market share of Bacille Calmette-Guerin Vaccine from 2019 to 2024.
    Chapter 3, the Bacille Calmette-Guerin Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bacille Calmette-Guerin Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Bacille Calmette-Guerin Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bacille Calmette-Guerin Vaccine.
    Chapter 14 and 15, to describe Bacille Calmette-Guerin Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now